Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China

By Kuwahara M.   Tochigi T.   Kawamura S.   Ogata Y.   Xu N.   Wang H.   Zhang H.   Li S.   Li X.   Zhao X.  

Urology, Vol. 61, Iss. 1, 2003-01 ,pp. : 137-141

Elsevier

Access to resources Recommend Favorite

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria 1

By Bartsch G.   Horninger W.   Klocker H.   Reissigl A.   Oberaigner W.   Schonitzer D.   Severi G.   Robertson C.   Boyle P.   the Tyrol Prostate Cancer Screening Group  

Urology, Vol. 58, Iss. 3, 2001-09 ,pp. : 417-424

Elsevier

Access to resources Recommend Favorite

Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populations

By Ito K.   Kubota Y.   Suzuki K.   Shimizu N.   Fukabori Y.   Kurokawa K.   Imai K.   Yamanaka H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 705-709

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

Non-systematic screening for prostate cancer in Sweden

By Stattin Pär   Johansson Robert   Damber Jan-Erik   Hellström Magnus   Hugosson Jonas   Lundgren Rolf   Varenhorst Eberhard   Johansson Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 37, Iss. 6, 2003-11 ,pp. : 461-465

Informa Healthcare

Access to resources Recommend Favorite